STERIS plc
NYSE:STE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
STERIS plc
NYSE:STE
|
IE |
|
K
|
Kajima Corp
SWB:KAJ
|
JP |
|
H
|
Heidelberg Pharma AG
XBER:HPHA
|
DE |
|
F
|
First Hydrogen Corp
OTC:FHYDF
|
CA |
Wall St Price Targets
STE Price Targets Summary
STERIS plc
According to Wall Street analysts, the average 1-year price target for STE is 269.95 USD with a low forecast of 227.25 USD and a high forecast of 309.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is STE's stock price target?
Price Target
269.95
USD
According to Wall Street analysts, the average 1-year price target for STE is 269.95 USD with a low forecast of 227.25 USD and a high forecast of 309.75 USD.
What is the Revenue forecast for STERIS plc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 7%.
What is the Gross Profit forecast for STERIS plc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 6 years is 8%.
What is the Operating Income forecast for STERIS plc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 4 years is 17%.
What is the Pre-Tax Income forecast for STERIS plc?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 4 years is 22%.
What is the Net Income forecast for STERIS plc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 6 years is 15%.
